MRVL vs REPL · P/E 100, rev $8.19B vs $825.7M cap
Marvell Technology Group Ltd (MRVL) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported MRVL revenue for 2026-01-31 was $8.19B. Net income was $2.67B. Revenue was up 42.1% from 2025-02-01 to 2026-01-31. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
REPL does not have a complete income-statement cache yet.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the MRVL and REPL stock pages for the full models.
Not investment advice.